ALDH2 and hepatocellular carcinoma: More recently, we have uncovered obesity-driven HCC in our mouse models with disruption of TGF-β signaling and loss of aldehyde dehydrogenase 2 (Aldh2) (Rao et al., 2021; Yang et al. 2024).